saying the drug is safe is very different than Nader and his 3 fingers. It's one of the central thesis points behind the drug and the investment. and we've had 1,000 people on the drug for 7 years.

he can easily say something more positive than what he said - even referencing past history of patients, but adding in "but we have an ongoing analysis we are adhering to". again, how many months has the entire team been working on just this issue as their top priority - lifting the hold, of which safety is the key point. i think we deserved more than that answer - but maybe that's just me.